Monoclonal antibodies have been around for decades. Antibody medicines like the one that earned President Donald Trump's praise after treatment earlier this month are not just for COVID-19. For the ...

Monoclonal antibodies -- treatments developed by cloning a cell that makes an antibody -- could help provide an answer to the growing problem of antimicrobial resistance, say scientists. Monoclonal ...

On 7 August 1975, Nature published a paper that has had some of the greatest impacts on science and health care in modern times. The study, by biochemists Georges Köhler and César Milstein, described ...

Michael Petrosky, MD, of Allegheny Health Network, spoke about the difference between vaccines and monoclonal antibodies and how they can affect treatment in respiratory syncytial virus (RSV). Michael ...

Identifying low-abundance monoclonal antibodies within a population of polyclonal antibodies provides insights for various applications, including understanding disease mechanisms, vaccine development ...

For the first time this fall, families will be offered season-long protection for infants and some children against respiratory syncytial virus (RSV). The US Food and Drug Administration (FDA) in July ...

Researchers have created an antibody that may neutralize SARS-CoV-2, offering potential prevention and treatment for the disease COVID-19, according to a study published May 4 in the scientific ...

Heparin-induced thrombocytopenia (HIT) is an immune-mediated platelet disorder caused by antibodies that target complexes of platelet factor 4 (PF4) and heparin. HIT has been characterized as a ...